Both approaches produce equivalent long-term results, with the conservative schedule offering fewer GI side effects during the escalation period
The results are not in the same league either
Preclinical research suggests potential neuroprotective effects, but human evidence for cognitive benefits remains limited and investigational
Commonly reported adverse events in trial reports (non-exhaustive) Gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) reported in controlled trials Decreased appetite Safety monitoring included additional endpoints and clinical assessments per protocol Does retatrutide cause hair loss
These conditions can present with abdominal symptoms and require prompt medical attention
Marketed as Victoza for type 2 diabetes (approved 2010) and Saxenda for chronic weight management (approved 2014), liraglutide paved the way for the current generation of GLP-1 weight loss medications, including its successor semaglutide